Ceryvyn Therapeutics (CYV) Short Interest
Ceryvyn Therapeutics (ASX:CYV) had 0.31% of shares reported as short positions as of 24 Aug 2026, representing 4,214,938 shares. Ceryvyn Therapeutics operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Ceryvyn Therapeutics
Short position
Ceryvyn Therapeutics (ASX:CYV) has 0.31% of its shares on issue reported as short positions as of 24 Aug 2026, or about 4,214,938 shares. Over the past 30 days that figure has been broadly flat, and over 7 days it has been broadly flat. CYV is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4CYV intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
About
Company information is being updated. Check back soon.
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss CYV
Start a research thread or post the first pulse update